06 January 2004
The influence of glimepiride on the binding kinetics of insulin with its skeletal muscle and liver receptors in rats with short term and prolonged hyperglycemia induced by streptozotocinHanna Krauss, Marian Grzymisławski, Jacek Koźlik, Przemysław Sosnowski, Jacek Piątek, Kinga Mikrut, Paweł Maćkowiak, Janusz Paluszak
Med Sci Monit 2004; 10(1): BR11-16 :: ID: 11554
Background:The aim of the study was to determine the influence of glimepiride on the binding kinetics of insulin with its skeletal muscle receptor in rats with transient and prolonged hyperglycemia induced by streptozotocin.Material/Methods: The studies were performed on healthy male Wistar rats with a body mass of 220±30 g, fed with LSM-type standard chow, and given water ad libitum. Transient or prolonged hyperglycemia was induced by intraperitoneal administration of streptozotocin. Blood samples were taken from the right heart ventricle to heparinized test tubes and centrifuged for 10 minutes at 700 i g. Plasma was collected and the glucose level was determined. From each animal 1 g of skeletal muscle and 1 g of liver were collected as well, placed in liquid nitrogen and stored until determination of the affinity and number of receptors.Results: We found an increase in affinity and binding capacity of high- and low-affinity receptors in rats with both transient and prolonged streptozotocin-induced hyperglycemia. The a ffinity and binding capacity of receptors increased under the influence of glimepiride in transient hyperglycemia caused by streptozotocin administration.Conclusions: The affinity and binding capacity of receptors increased under the influence of glimepiride in the course of transient hyperglycemia. The lack of changes in the specific insulin binding and binding capacity of receptors of both low and high affinity in the group of animals with prolonged hyperglycemia requires explanation.
Keywords: Hyperglycemia - chemically induced, Hyperglycemia - drug therapy, Hyperglycemia - metabolism, Hypoglycemic Agents - pharmacology, Insulin - metabolism, Kinetics, Liver - drug effects, Liver - metabolism, Muscle, Skeletal - drug effects, Muscle, Skeletal - metabolism, Rats, Wistar, Receptor, Insulin - drug effects, Receptor, Insulin - metabolism, Streptozocin - toxicity, Sulfonylurea Compounds - pharmacology, Hyperglycemia - metabolism, Hypoglycemic Agents - pharmacology, Insulin - metabolism, Kinetics, Liver - metabolism, Muscle, Skeletal - metabolism, Rats, Wistar, Receptor, Insulin - metabolism, Streptozocin - toxicity, Sulfonylurea Compounds - pharmacology
01 May 2023 : EditorialEditorial: Twenty Years On from Sequencing the Human Genome, Personalized/Precision Oncology Prepares to Meet the Challenges of Checkpoint Inhibitor Therapy
Med Sci Monit 2023; 29:e940911
31 May 2023 : Review articlePrevalence, Diagnosis, and Management of Eclampsia and the Need for Improved Maternal Care: A Review
Med Sci Monit In Press; DOI: 10.12659/MSM.939919
30 May 2023 : Clinical ResearchA Case-Control Study of Cognitive Function in Patients with End-Stage Renal Disease Before and After Hemodi...
Med Sci Monit In Press; DOI: 10.12659/MSM.940409
30 May 2023 : Review articleA Review of the Role of the Zebrafish (Danio reiro) in Preclinical and Clinical Models of Biomarker Identif...
Med Sci Monit In Press; DOI: 10.12659/MSM.940550
30 May 2023 : Database AnalysisThe COVID-19 Crisis and the Incidence of Alcohol-Related Deaths in Poland
Med Sci Monit In Press; DOI: 10.12659/MSM.940904
Most Viewed Current Articles
13 Nov 2021 : Clinical ResearchAcceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...
Med Sci Monit 2021; 27:e932788
30 Dec 2021 : Clinical ResearchRetrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...
Med Sci Monit 2021; 27:e935379
08 Mar 2022 : Review articleA Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...
Med Sci Monit 2022; 28:e936292
01 Jan 2022 : EditorialEditorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...
Med Sci Monit 2022; 28:e935952